Take Your PICS: Moving from GWAS to Immune Function  by Eyre, Stephen & Worthington, Jane
Immunity
PreviewsTake Your PICS: Moving from GWAS
to Immune FunctionStephen Eyre1,2 and Jane Worthington1,2,*
1Arthritis Research UK Centre for Genetics and Genomics, Centre for Musculoskeletal Research, Institute of Inflammation and Repair,
Faculty of Medical and Human Sciences, University of Manchester, Oxford Road, Manchester M13 9PT, UK
2NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester NHS Foundation Trust, Manchester Academic Health
Sciences Centre, Manchester M13 9PT, UK
*Correspondence: jane.worthington@manchester.ac.uk
http://dx.doi.org/10.1016/j.immuni.2014.12.014
Many of the hits identified through genome-wide association studies are located outside protein-coding
regions, making it difficult to definemechanism. InNature, Farh et al., (2014) describe an approach to identify
causal variants in autoimmune disease as first step to assigning function.Although genome-wide association
studies (GWASs) have provided insights
into disease pathology and supported es-
tablished theories about the importance
of the role of T cells, antigen presenta-
tion, and cytokine production in autoim-
mune disease, the signals are often
difficult to interpret, and relatively few
GWAS hits have been assigned a mo-
lecular function. A common feature of
GWASs is that the vast majority of signals
(up to 90%) lie outside traditional protein-
coding gene sequences. There is now
growing evidence that these GWAS sig-
nals are enriched in cell-type-specific
(Trynka et al., 2013), large active regula-
tory regions of the genome (Maurano
et al., 2012), known as superenhancers
(Hnisz et al., 2013). Based on the analysis
of 21 autoimmune GWASs, a recent
Nature paper by Farh et al. describes
the development of a unique resource
for assigning a probability of single
nucleotide polymorphisms (SNPs) being
causal in disease (Farh et al., 2014). A se-
ries of epigenetic analyses revealed that
60% of these likely causal variants are
located within stimulus and cell-type-
specific enhancers, enriched for both his-
tone modifications and the transcription
of noncoding RNA.
Using 39 large-scale GWAS studies
from a range of traits (21 of which were
from autoimmune diseases), Farh et al.
initially clustered diseases by their shared
genetic loci. Unsurprisingly, this indicated
a large overlap for immune-related traits,
with 69% of genes for each trait shared
by at least one other autoimmune dis-
ease. In addition, it revealed a higher
degree of clustering between diseaseswithin the general ‘‘autoimmune’’ cate-
gory. This included evidence for shared
genetics between type 1 diabetes and
juvenile idiopathic arthritis (but, perhaps
surprisingly, not rheumatoid arthritis),
psoriasis, ankylosing spondylitis and
Crohn’s disease, and multiple sclerosis
and celiac disease. The authors went
on to provide an algorithm (PICS) and
easy-to-access portal that allows a SNP
to be assigned a probability score
of being a causal variant. Currently, re-
searchers attempting to integrate disease
causal variants with functional assays
select the SNPs for investigation from
the GWAS Catalogue (www.genome.
gov/gwastudies). This catalog provides
the lead associated SNP for all loci pass-
ing the established GWAS significance
threshold of p < 5 3 108. The GWAS ar-
rays used to detect these associations
are designed such that each genotyped
SNP strongly correlates with a large
number of ungenotyped SNPs, allowing
comprehensive GWA analysis. Unfortu-
nately, this has the downside that the
lead GWAS SNP implicates a large num-
ber of ungenotyped SNPs, some a large
distance from the genotyped association
and unlikely to be the causal variant.
Inevitably, this might lead to large
numbers of potentially causal variants
requiring downstream functional assays.
Farh et al. developed a fine-mapping
algorithm to refine the set of likely causal
variants from GWAS signals. The correla-
tion of SNPs along a chromosome is
termed a haplotype, and the authors
used large data sets (over 38,000 sam-
ples) to capture rare breaks (recombina-
tion events) in these haplotypes; this,Immunity 41, Dalong with the strength of association at
each region, is used to assign each
SNP in a region a probabilistic value for
being disease causal. The database
described by Farh et al. is, therefore, a
major step forward in quickly prioritizing
a SNP, or more likely group of SNPs, as
being responsible for the association
signal seen in disease. In fact, the authors
went on to show that the ‘‘lead’’
SNP highlighted in the GWAS catalog
described above has only a 5% chance
of being causal and lies on average 14
kb from the predicted true causal SNP.
Further reinforcement is provided by the
illustration that the ‘‘PICS’’ SNPs are
better at predicting functional annotation
than the GWAS catalog SNPs.
Histone modifications are established
markers of different chromatin states,
and methylation (Me) or acetylation (Ac)
of specific histones strongly correlate
with promoter or enhancer position and
activity (Ernst et al., 2011). For example,
histone H3 lysine 3 monomethylation
(H3K3Me1) is known to correlate with
‘‘poised’’ (open and accessible regions
of the DNA, but not actively driving
gene expression) enhancers, whereas
H3K27Ac marks active enhancers. Farh
et al. went on to examine epigenetic
marks in primary human blood immune
cells, including resting and stimulated
CD4+ T cell subsets, regulatory T cells,
CD8+ T cells, B cells, and monocytes, un-
der different stimulatory conditions. They
found different cell types clustered
according to cis-regulatory element
patterns, and based on clusters of
enhancers, cell-type- and stimulation-
specific patterns of histone modificationsecember 18, 2014 ª2014 Elsevier Inc. 883
Figure 1. Schematic Diagram of a Generalized Autoimmune Disease Susceptibility Locus
Lead SNPs from GWASs (purple triangle) are correlated with multiple SNPs (blue triangles) at a suscepti-
bility locus. Evidence from the paper by Farh et al. indicates that SNPs with the highest probability of being
causal (PICS SNPs, red triangle) can lie some distance from the GWAS SNP (median 14 kb). They also
show that 90% of PICS SNPs are found outside gene regions, whereas 60% are within enhancer regions.
As indicated in the schematic, they find that PICS SNPs are enriched for residing in superenhancers, within
discrete enhancer regions, and usually lie close to, but outside, transcription factor-binding motifs.
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Previewscould be determined. Interestingly, the
mark for active enhancers (H3K27ac)
was found to be more specific for
defining cell-type-specific activity than
the H3K4me1 mark for poised en-
hancers. Enhancer activity is known to
correlate with local gene expression,
and using the PICS SNPs defined by
Farh et al., potentially causal autoimmune
SNPs were found enriched in stimula-
tory-specific enhancers, with probable
disease-causing variants detected in
enhancer regions 60% of the time, but
in promoter regions only 8% of the time.
Subsequent experiments indicated that
the potentially causal variants were found
in superenhancers but were confined to
discrete regions (Figure 1). Specific anal-
ysis of the IL2RA region supported the
idea that different causal variants occur
in different discrete regions of the super-
enhancer for different diseases and might
well play specific roles in different cell
types. For example, PICS SNPs physi-
cally close to each other in the IL2RA
superenhancer are either associated
with autoimmune thyroiditis or multiple
sclerosis, but not both. These SNPs clus-
ter in two discrete enhancer units within
the superenhancer, showing a different
pattern of activity in different cell sub-
types. Further annotation of the causal884 Immunity 41, December 18, 2014 ª2014SNPs indicated an enrichment for
enhancer RNA expression, a known
marker for enhancer activity, in the impli-
cated cell types, suggesting that the
region that contains the PICS SNP is
indeed active in gene regulation. Finally
the authors found that, although causal
SNPs often map very close to tran-
scription factor binding motifs (within
100 bp), they rarely disrupt the motif it-
self, suggesting that disease SNPs might
not interfere directly with binding of
transcription factors; however, as yet,
the mechanism via which they operate
is unknown.
Theauthorsalso report, perhaps surpris-
ingly,a lackofevidence thatdiseasecausal
SNPs correlate strongly with expression of
genes (eQTL). As they acknowledge, this
might reflect the fact that whole blood
was used as the source of eQTL data,
whereas disease SNPs are thought to
have more subtle effects depending on
the cell-type and stimulatory conditions.
By mapping of causal variants to cell-
type- and stimulatory-specific enhancers,
thepaper showshow the effects of disease
causal variants might be restricted to
certain cell types. It is no surprise to see
autoimmune diseases associated with
causal SNPs located in enhancers regions
active in T cell subtypes and B cells.Elsevier Inc.This paper illustrates the possibility to
take findings from GWASs through to
identification of functional variants and
generation of hypotheses about disease
mechanisms. It sets a standard for how
to use the wealth of data being generated
from large-scale international efforts, such
as Blueprint (Martens and Stunnenberg
2013), Encode (ENCODE Project Con-
sortium, 2012), and Epigenetic Roadmap
(Bernstein et al., 2010) and will transform
theway in which genomic and immunoge-
netic studies are performed. Informed
interrogation of these combined re-
sources should underpin the better design
of experiments to investigate the immuno-
logical consequences of disease-associ-
ated genetic variation. Researchers will
have improved knowledge of the genetic
architecture of a disease locus—not just
the lead variant but the potential causative
SNP(s) that might be some genomic dis-
tance away; they will also know the cell-
type and stimulatory conditions most
relevant to the specific gene, pathway,
and disease of interest. Indeed, the au-
thors provide a simple interface to allow
researchers to search for SNPs and an
easy-to-use portal to determine which
cell-type, stimulatory condition andepige-
neticmark ismost informative for the gene
of interest. It is nowpossible to determine,
for example, that four SNPs each have a
23% chance of being causal for the dis-
ease of interest, that they all map within a
discrete unit of a superenhancer, which
is active in CD4+ T cells stimulated to
become T helper 17 cells, and that the ge-
notype leads to a 20% increase in tran-
scription of a key immune gene. This infor-
mation then has the capacity to inform
study designs to mimic the mode of ac-
tion, in primary cells or in vivo models, to
illuminate the mechanism by which ge-
netic variants increase the risk of disease.
The authors, then, have advanced
knowledge of causal variants for autoim-
mune diseases, finding that they are
enriched in discrete, stimulus dependent
regions of superenhancers, correlate
with eRNA and histone acetylation and,
although often close to transcription fac-
tor motifs, rarely alter the motif itself. In
addition, they provide valuable and user-
friendly data resources to ensure studies
attempting to translate genetic findings
to functional effects do so armed with
empirical data on how to improve study
design.
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